Date: 27 June 2019
The RACGP provided input on the recent PBAC review of pneumococcal vaccines in older adults. Emphasis was placed on the importance of a sound evidence-base for the removal of any vaccine from the NIP.
The RACGP response covers the following:
- Vaccine effectiveness and cost effectiveness against invasive pneumococcal disease and community-acquired pneumonia
- The impact of removing a vaccine from the National Immunisation Program.